2,3,7,8-tetrachlorodibenzo-p-dioxin does not directly alter the phenotype of maturing B cells in a murine coculture system

被引:9
作者
Wyman, A
Lavin, AL
Wilding, GE
Gasiewicz, TA
机构
[1] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY 14642 USA
[2] Univ Rochester, Sch Med & Dent, Dept Biostat, Rochester, NY 14642 USA
关键词
aryl hydrocarbon receptor; B lymphopoiesis; stromal cells; TCDD; bone marrow; coculture;
D O I
10.1006/taap.2002.9396
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), acting through the aromatic hydrocarbon receptor (AhR), elicits numerous toxicological effects, including immunosuppression. Previous work from our laboratory has suggested that TCDD exposure in mice is associated with altered lymphopoietic development, in particular altered B-cell phenotype in the bone marrow. It remains to be determined which specific hematopoietic populations or subpopulations within the marrow cavity are directly targeted by TCDD. To examine the effects of TCDD on developing B cells in vitro, a stromal coculture model was used. Primary bone marrow cells from male, 6- to 7-week-old C57B1/6 mice were cocultured separately on two AhR-containing stromal cell lines (M2-10B4 and S17) that support B-cell development in the presence of IL-7. The cocultures were treated with 0 to 10 nM TCDD. Shifts in phenotype were quantified by cell surface marker staining and flow cytometry. Four populations in the maturing B cell (very early pre-pro-B, pre-pro-B, pro-B, and pre-B) were defined for quantification. The results show that the only statistically significant effect of TCDD was within the pre-pro-B population in cultures with the S17 stromal cell line. The increase in number of cells with this phenotype was seen in cultures with both wild-type and AhR-/- primary bone marrow cells. These results suggest that the maturing B220+ B cell is not the direct target for TCDD-induced bone marrow B-cell alterations. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:164 / 177
页数:14
相关论文
共 47 条
[1]   SELECTIVE-INHIBITION OF POLYMORPHONUCLEAR NEUTROPHIL ACTIVITY BY 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN [J].
ACKERMANN, MF ;
GASIEWICZ, TA ;
LAMM, KR ;
GERMOLEC, DR ;
LUSTER, MI .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1989, 101 (03) :470-480
[2]   Lymphoid development from stem cells and the common lymphocyte progenitors [J].
Akashi, K ;
Kondo, M ;
Cheshier, S ;
Shizuru, J ;
Gandy, K ;
Domen, J ;
Mebius, R ;
Traver, D ;
Weissman, IL .
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1999, 64 :1-12
[3]  
BILLIPS LG, 1992, BLOOD, V79, P1185
[4]  
COLLINS LS, 1987, J IMMUNOL, V138, P1082
[5]   Leukocyte activation induces aryl hydrocarbon receptor up-regulation, DNA binding, and increased Cyp1a1 expression in the absence of exogenous ligand [J].
Crawford, RB ;
Holsapple, MP ;
Kaminski, NE .
MOLECULAR PHARMACOLOGY, 1997, 52 (06) :921-927
[6]   THE INFLUENCE OF S17 STROMAL CELLS AND INTERLEUKIN-7 ON B-CELL DEVELOPMENT [J].
CUMANO, A ;
DORSHKIND, K ;
GILLIS, S ;
PAIGE, CJ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (10) :2183-2189
[7]   GENERATION OF PURIFIED STROMAL CELL-CULTURES THAT SUPPORT LYMPHOID AND MYELOID PRECURSORS [J].
DORSHKIND, K ;
JOHNSON, A ;
COLLINS, L ;
KELLER, GM ;
PHILLIPS, RA .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 89 (01) :37-47
[8]  
Dorshkind K, 1992, Curr Top Microbiol Immunol, V182, P13
[9]   REGULATION OF B-CELL DIFFERENTIATION BY BONE-MARROW STROMAL CELLS [J].
DORSHKIND, K ;
LANDRETH, KS .
INTERNATIONAL JOURNAL OF CELL CLONING, 1992, 10 (01) :12-17
[10]   REGULATION OF HEMATOPOIESIS BY BONE-MARROW STROMAL CELLS AND THEIR PRODUCTS [J].
DORSHKIND, K .
ANNUAL REVIEW OF IMMUNOLOGY, 1990, 8 :111-137